Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β‑catenin signaling pathway
Cited by 12
Related Papers
RANKL inhibition: a new target of treating diabetes mellitus?
|Therapeutic Advances in Endocrinology and Metabolism|2023|22
Slit2-Robo1 signaling promotes the adhesion, invasion and migration of tongue carcinoma cells via upregulating matrix metalloproteinases 2 and 9, and downregulating E-cadherin
|Molecular Medicine Reports|2016|20
Successful treatment of type B insulin resistance with mixed connective tissue disease by pulse glucocorticoids and cyclophosphamide
|Journal of Diabetes Investigation|2017|13